Rebecca A. Byam - 22 May 2023 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Financial Officer
Signature
/s/ Rebecca A. Byam
Issuer symbol
HCWB
Transactions as of
22 May 2023
Net transactions value
+$91,082
Form type
4
Filing time
24 May 2023, 17:25:37 UTC
Previous filing
03 Nov 2022
Next filing
31 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCWB Common Stock Purchase $51,045 +33,450 +9.2% $1.53 395,152 22 May 2023 Direct F1
transaction HCWB Common Stock Purchase $7,887 +5,036 +1.3% $1.57 400,188 23 May 2023 Direct F2
transaction HCWB Common Stock Purchase $32,150 +20,000 +5% $1.61 420,188 24 May 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The range of prices for the shares of Common Stock is from $1.50 to $1.54. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
F2 The range of prices for the shares of Common Stock is from $1.57 to $1.60. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
F3 The range of prices for the shares of Common Stock is from $1.52 to $1.70. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.